Cost-effectiveness analysis of 'test and treat' policy for antiretroviral therapy among heterosexual HIV population in India
- Resource Type
- article
- Authors
- Malkeet Singh; Aman Sharma; Pankaj Bahuguna; Gaurav Jyani; Shankar Prinja
- Source
- Indian Journal of Medical Research, Vol 156, Iss 6, Pp 705-714 (2022)
- Subject
- antiretroviral therapy - cd4 - cost-effectiveness analyses - economic evaluation - hiv - india – modelling - test and treat
Medicine
- Language
- English
- ISSN
- 0971-5916
16803396
Background & objectives: The World Health Organisation recommended immediate initiation of antiretroviral therapy (ART) in all adult human immunodeficiency virus (HIV) patients regardless of their CD4 cell count. This study was undertaken to ascertain the cost-effectiveness of implementation of these guidelines in India. Methods: A Markov model was developed to assess the lifetime costs and health outcomes of three scenarios for initiation of ART treatment at varying CD4 cell count